Angelman syndrome (AS) and PraderWilli syndrome (PWS) have become the classical examples of genomic imprinting in man, as completely different phenotypes are generated by the absence of maternal (AS) or paternal (PWS) contributions to the qll-13 region of chromosome 15 as a result of deletion or uniparental disomy. Apparently, most patients are sporadic cases. The genetic mechanism underlying familial AS has remained enigmatic for a long time. Recently, evidence has been emerging suggesting autosomal dominant inheritance of a detectable or undetectable defect in a gene or genes at 15ql 1-13, subject to genomic imprinting. The present report describes an unusually large pedigree with segregation of AS through maternal inheritance and apparent asymptomatic transmission through several male ancestors. Deletion and paternal disomy at 15ql1-13 were excluded. However, the genetic defect is still located in this region, as we obtained a maximum lod score of 5 40 for linkage to the GABA receptor locus GABRB3 and the anonymous DNA marker DISSlO, which have been mapped within or adjacent to the AS critical region at 15qll-13.
suggesting autosomal dominant inheritance of a detectable or undetectable defect in a gene or genes at 15ql 1-13, subject to genomic imprinting. The present report describes an unusually large pedigree with segregation of AS through maternal inheritance and apparent asymptomatic transmission through several male ancestors. Deletion and paternal disomy at 15ql1-13 were excluded. However, the genetic defect is still located in this region, as we obtained a maximum lod score of 5 40 for linkage to the GABA receptor locus GABRB3 and the anonymous DNA marker DISSlO, which have been mapped within or adjacent to the AS critical region at 15qll-13.
The size of the pedigree allowed calculation of an odds ratio in favour of genomic imprinting of 9 25 x 105. This family illustrates the necessity of extensive pedigree analysis when considering recurrence risks for relatives of AS patients, those without detectable deletion or disomy in particular. ( The main features of Angelman syndrome (AS) are severe mental retardation, absent speech, paroxysms of laughter, abnormal gait, seizures or EEG abnormalities, microcephaly, brachycephaly, macrostomia, and prognathism. ' 19 We present a family of exceptional size as it spans five generations with AS occurring in several sibships. Maternal inheritance was apparent in each case. Asymptomatic transmission through several male ancestors could be inferred from the pedigree. Cytogenetic analysis was performed to study chromosomal rearrangements in the patients and their mothers. Molecular and statistical analyses were applied to investigate subtle deletions or uniparental disomy involving 15q, linkage between AS and markers on 15q, and to determine the mode of inheritance.
Materials and methods

PATIENTS
The pedigree of a five generation Caucasian family with eight AS patients is shown in fig 1. Seven of the patients showed typical features of AS, including severe mental retardation, absent speech, and frequent laughter and smiling (table 1) . Before this family presented to us, the only patient in generation III ( fig 1) had died at the age of 53 years. Her medical records and photographs confirmed that she was also affected with AS. Patient V.3 was seen at the age of 10 months and all other patients and family members investigated were older than 10 years. Seven patients had EEG abnormalities, while two patients, IV.10 and III.x, had seizures. Strabismus was seen in patients V.1, V.3, IV.6, and III.x. Fig 2A and B show the development of the facial dysmorphism in patient IV.10. Fig 2C shows Chromosome analysis on lymphocytes of patients V.1, V.3, IV.6, IV.7, IV.15, and IV.16 was performed using standard techniques. High resolution GTG banding was applied to study one of the patients (IV. 10) in more detail. In order to enable detection of a familial translocation of chromosome 15 in its unbalanced form, the patients' mothers, IV.2, III.8, III.10, and III.13, were also karyotyped.
DNA ANALYSIS
Blood samples for DNA analysis were collected from 38 subjects, as indicated in fig 1, representing three generations and including all available nuclear families with affected offspring. DNA from leucocytes was isolated according to Miller et al.202 ' Dinucleotide (CA) repeat markers at GABRB3 and D1SS1O were analysed using radiolabelled PCR conditions essentially as previously described. 
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Linkage analysis with chromosome 15qll-13 markers shows genomic imprinting in familial Angelman syndrome analysis by Southern blotting and hybridisation using standard methods involved the following probes from 15qll-13: pIR39 (locus D1SS18), pTD 189.1 (D1SS13), pML34 (D1SS9), pIR4-3R (DISS11), pTD3-21 (DISS1O), and pIR10-1 (D15S12)."
LINKAGE ANALYSIS
All linkage calculations were carried out with the MLINK option of the LINKAGE package of computer programs (version 5.03).23 Equal allele frequencies were assumed for the marker loci. The disease allele was given a frequency of 0-001 in the calculations, but it was assumed that only a single AS mutation segregated in this family. Calculations were carried out under two models: one with 50% penetrance for all subjects heterozygous for the autosomal dominant disease allele (absence of the disease phenotype in gene carriers is explained by random effects leading to 50% penetrance), and another model with complete penetrance for subjects who had inherited the disease allele from their mother, while paternal inheritance was assumed never to lead to expression of the mutation (absence of the disease phenotype in gene carriers is solely the effect of genomic imprinting). Odds for imprinting were calculated by comparing the maximum likelihood obtained under the model of imprinting and linkage with the maximum likelihood allowing for linkage but not for imprinting.
Subjects V.1, V.3, IV.6, III.x, IV.7, IV.10, IV.15, and IV.16 were considered to be affected, while all other family members were considered to be unaffected.
In the multipoint analysis the distance between GABRB3 and D15S10 was fixed at 1 cM, based on the observation of a single recombination event between these loci in this pedigree. Recombination frequencies in males and females were assumed to be equal.
Results
CYTOGENETIC AND DNA ANALYSIS
Chromosome analysis showed normal karyotypes in all seven investigated patients and their mothers, with no cytogenetically visible deletions or translocations involving chromosome 15q.
DNA marker analysis showed heterozygosity at GABRB3 in all patients and at D15S10 (CA repeat) in two patients (fig 1) . Heterozygosity was also observed at D15S1 in the DNA of four patients when analysing the StyI and RsaI polymorphisms detected by IR4-3R (not shown). The hybridisation patterns obtained by Southern blotting using other RFLP markers from chromosome 15qll-13 were all in agreement with the presence of two alleles in the patients' DNA. Hence, we were unable to detect a deletion in the chromosomal region we investigated at the molecular level. Moreover, the heterozygous patterns at GABRB3 were of unequivocal biparental origin in five of the patients (fig 1) . The maternal allele could also be distinguished with certainty in the four patients who were heterozygous at D15S1 (not shown). Assuming that one genetic defect segregates in this family this rules out paternal disomy at these loci as the cause of AS in this family.
LINKAGE ANALYSIS
We noticed that the same allele, numbered 3 in fig 1, at GABRB3 was found in all seven patients investigated, their mothers, and the only living grandparent (III.1), whereas this allele was not observed in unaffected sibs of patients ( fig 1) . Next, we analysed whether the genetic defect in this family showed linkage to GABRB3 and DISSIO. Table 2 Lod scores between AS and CA repeats at the GABRB3 locus and at DISS1O at various recombination fractions. Lod scores were calculated assuming two different models: one with 50% penetrance of all heterozygotes for the disease allele (no imprinting), and one with complete penetrance for subjects who had inherited the disease allele from their mother, while paternal inheritance was assumed never to lead to expression of the mutation. Further molecular genetic analysis of nondeletion AS patients will be essential to determine the gene(s) involved in the pathogenesis of AS. Our data do not contradict a possible role of the GABRB3 gene in the pathogenesis of AS as no recombinations were detected between AS and this locus in the entire family. The consistent lack of PWS in the offspring of the male carriers of an AS mutation adds to the evidence that distinct defects are involved in the aetiologies of AS and PWS. In our family non-penetrance as an explanation for the lack of PWS offspring was highly unlikely as multiple transmissions of the mutation occurred through male meioses without phenotypic expression of PWS.
The influence of genomic imprinting on the expression of mutation has been described in a growing number of human genetic diseases. 25 Hereditary paraganglioma is another example where the role of genomic imprinting in the phenotypic expression in an extended family has been shown to be absolute. 26 The recent implication of genomic imprinting in familial AS may complicate genetic counselling. In familial AS cases, an X linked mode of inheritance may falsely be deduced when the syndrome diagnosis is overlooked. On the other hand, imprinting may obscure the hereditary nature of the defect owing to the lack of phenotypic expression in offspring of male carriers. If a genetic defect at 15qll-13 and consequently genomic imprinting are a universal phenomenon in familial AS, unaffected sibs of AS patients would have no increased risk for AS in their offspring. Risk assessments for more distant female relatives of AS patients, particularly those without detectable genetic defects, would necessarily involve an extensive search of the pedigree for AS.
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